Bank of Montreal’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-56,861
| Closed | -$354K | – | 4268 |
|
|
2024
Q2 | $354K | Buy |
+56,861
| New | +$294K | ﹤0.01% | 2627 |
|
|
2023
Q3 | – | Sell |
-298,581
| Closed | -$1.99M | – | 4264 |
|
|
2023
Q2 | $1.99M | Buy |
298,581
+287,520
| +2,599% | +$1.84M | ﹤0.01% | 1830 |
|
|
2023
Q1 | $81K | Buy |
+11,061
| New | +$77.8K | ﹤0.01% | 3285 |
|
|
2022
Q2 | – | Sell |
-14,605
| Closed | -$173K | – | 4477 |
|
|
2022
Q1 | $173K | Sell |
14,605
-81
| -0.6% | -$1.06K | ﹤0.01% | 3510 |
|
|
2021
Q4 | $246K | Sell |
14,686
-696,777
| -98% | -$12.1M | ﹤0.01% | 2856 |
|
|
2021
Q3 | $12.3M | Sell |
711,463
-3,297
| -0.5% | -$57.7K | 0.01% | 1173 |
|
|
2021
Q2 | $14.9M | Buy |
714,760
+593,804
| +491% | +$10.6M | 0.01% | 1061 |
|
|
2021
Q1 | $2.01M | Sell |
120,956
-19,155
| -14% | -$310K | ﹤0.01% | 1800 |
|
|
2020
Q4 | $1.96M | Sell |
140,111
-111,979
| -44% | -$1.35M | ﹤0.01% | 1837 |
|
|
2020
Q3 | $2.54M | Sell |
252,090
-9,516
| -4% | -$102K | ﹤0.01% | 1570 |
|
|
2020
Q2 | $3.03M | Buy |
261,606
+4,500
| +2% | +$51K | ﹤0.01% | 1423 |
|
|
2020
Q1 | $2.83M | Sell |
257,106
-4,001
| -2% | -$49.6K | ﹤0.01% | 1261 |
|
|
2019
Q4 | $4.29M | Buy |
261,107
+182,360
| +232% | +$2.76M | ﹤0.01% | 1443 |
|
|
2019
Q3 | $1.05M | Buy |
78,747
+16,159
| +26% | +$225K | ﹤0.01% | 2056 |
|
|
2019
Q2 | $882K | Sell |
62,588
-5,731
| -8% | -$91.2K | ﹤0.01% | 2133 |
|
|
2019
Q1 | $1.26M | Sell |
68,319
-13,662
| -17% | -$311K | ﹤0.01% | 1928 |
|
|
2018
Q4 | $2.14M | Sell |
81,981
-10,398
| -11% | -$244K | ﹤0.01% | 1486 |
|
|
2018
Q3 | $2.12M | Buy |
92,379
+15,030
| +19% | +$307K | ﹤0.01% | 1644 |
|
|
2018
Q2 | $1.47M | Sell |
77,349
-1,533
| -2% | -$25.6K | ﹤0.01% | 1794 |
|
|
2018
Q1 | $1.33M | Buy |
78,882
+7,027
| +10% | +$118K | ﹤0.01% | 1774 |
|
|
2017
Q4 | $1.09M | Sell |
71,855
-2,910
| -4% | -$43.2K | ﹤0.01% | 1908 |
|
|
2017
Q3 | $1.34M | Sell |
74,765
-6,482
| -8% | -$108K | ﹤0.01% | 1828 |
|
|
2017
Q2 | $1.32M | Buy |
81,247
+70,727
| +672% | +$1.02M | ﹤0.01% | 1856 |
|
|
2017
Q1 | $147K | Sell |
10,520
-456
| -4% | -$6.5K | ﹤0.01% | 2631 |
|
|
2016
Q4 | $181K | Buy |
10,976
+2,447
| +29% | +$39.3K | ﹤0.01% | 2541 |
|
|
2016
Q3 | $142K | Sell |
8,529
-3,253
| -28% | -$43.8K | ﹤0.01% | 2599 |
|
|
2016
Q2 | $132K | Sell |
11,782
-1,075,537
| -99% | -$10.4M | ﹤0.01% | 2684 |
|
|
2016
Q1 | $9.09M | Sell |
1,087,319
-121,599
| -10% | -$998K | 0.01% | 770 |
|
|
2015
Q4 | $11.3M | Buy |
1,208,918
+228,074
| +23% | +$2.28M | 0.01% | 675 |
|
|
2015
Q3 | $11.1M | Buy |
980,844
+117,822
| +14% | +$1.44M | 0.02% | 664 |
|
|
2015
Q2 | $11M | Buy |
+863,022
| New | +$9.31M | 0.01% | 756 |
|
|
2014
Q3 | – | Sell |
-860
| Closed | -$14K | – | 4423 |
|
|
2014
Q2 | $14K | Buy |
+860
| New | +$11.5K | ﹤0.01% | 3742 |
|
Other funds holding VNDA
TCM
NCM
Bank of Montreal's VNDA Position: Q3 2024 in Review
Bank of Montreal sold out of Vanda Pharmaceuticals (VNDA) in Q3 2024, closing a stake of 56,861 shares — an estimated $354K sold.
Bank of Montreal first reported a position in VNDA in Q2 2014 and held it in 32 quarters. The position peaked at $14.9M in Q2 2021. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.
- Bank of Montreal reported no remaining Vanda Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- Bank of Montreal sold 56,861 Vanda Pharmaceuticals shares in Q3 2024, an estimated $354K.
- Bank of Montreal first reported a position in Vanda Pharmaceuticals in Q2 2014 and held it in 32 quarters.
- Bank of Montreal's Vanda Pharmaceuticals position peaked at $14.9M in Q2 2021.
- 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.
Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.